Heterogeneity in diabetes-associated autoantibodies and susceptibility to Type 1 diabetes: lessons for disease prevention

References

• Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279-83
   PubMed Web of Science ®Google Scholar
• Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011;57:168-75
   PubMedGoogle Scholar
• Andersson C, Kolmodin M, Ivarsson SA, et al. Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies. Pediatr Diabetes 2014;15:336-44
   PubMedGoogle Scholar
• Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet 2014;383:69-82
   PubMed Web of Science ®Google Scholar
• Canivell S, Gomis R. Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev 2014;13:403-7
   PubMed Web of Science ®Google Scholar
• Andersson C, Larsson K, Vaziri-Sani F, et al. The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes. Autoimmunity 2011;44:394-405
   PubMed Web of Science ®Google Scholar
• McDonald TJ, Ellard S. Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem 2013;50:403-15
   PubMed Web of Science ®Google Scholar
• Libman IM, Pietropaolo M, Arslanian SA, et al. Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children. Diabetes Care 2003;26:2876-82
   PubMed Web of Science ®Google Scholar
• Wang J, Miao D, Babu S, et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. J Clin Endocrinol Metab 2007;92:88-92
   PubMed Web of Science ®Google Scholar
• Thunander M, Petersson C, Jonzon K, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 2008;82:247-55
   PubMed Web of Science ®Google Scholar
• Leslie RD. Predicting adult-onset autoimmune diabetes: clarity from complexity. Diabetes 2010;59:330-1
   PubMedGoogle Scholar
• Andersen MK, Härkönen T, Forsblom C, et al. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes. Autoimmunity 2013;46:251-8
   PubMed Web of Science ®Google Scholar
• Cervin C, Lyssenko V, Bakhtadze E, et al. Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 2008;57:1433-7
   PubMed Web of Science ®Google Scholar
• Grant SF, Hakonarson H, Schwartz S. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? Endocr Rev 2010;31:183-93
   PubMedGoogle Scholar
• Bonifacio E, Bingley PJ, Shattock M, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-9
   PubMed Web of Science ®Google Scholar
• Siljander HT, Simell S, Hekkala A, et al. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 2009;58:2835-42
   PubMed Web of Science ®Google Scholar
• Steck AK, Johnson K, Barriga KJ, et al. Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young. Diabetes Care 2011;34:1397-9
   PubMed Web of Science ®Google Scholar
• Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013;309:2473-9
   PubMed Web of Science ®Google Scholar
• Knip M, Kukko M, Kulmala P, et al. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. Am J Med Genet 2002;115:48-54
   Google Scholar
• Tait BD, Colman PG, Morahan G, et al. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 2003;61:146-53
   PubMedGoogle Scholar
• Lipponen K, Gombos Z, Kiviniemi M, et al. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 2010;59:3253-6
   PubMedGoogle Scholar
• Mbunwe E, Van der Auwera BJ, Weets I, et al. In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions. Diabetologia 2013;56:1964-70
   PubMedGoogle Scholar
• Parikka V, Nänto-Salonen K, Saarinen M, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 2012;55:1926-36
   PubMedGoogle Scholar
• Ziegler AG, Bonifacio E, Group B-BS. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia. 2012;55:1937-43
   Google Scholar
• Hummel M, Bonifacio E, Schmid S, et al. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents. Ann Intern Med 2004;140:882-6
   PubMed Web of Science ®Google Scholar
• Komulainen J, Kulmala P, Savola K, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes Care 1999;22:1950-5
   PubMed Web of Science ®Google Scholar
• Ziegler AG, Standl E, Albert E, Mehnert H. HLA-associated insulin autoantibody formation in newly diagnosed type I diabetic patients. Diabetes 1991;40:1146-9
   PubMedGoogle Scholar
• Genovese S, Bonfanti R, Bazzigaluppi E, et al. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996;39:1223-6
   PubMedGoogle Scholar
• Kockum I, Lernmark A, Dahlquist G, et al. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. The Swedish Childhood Diabetes Study Group and The Diabetes Incidence in Sweden Study (DISS) Group. Horm Metab Res 1996;28:344-7
   PubMedGoogle Scholar
• Sabbah E, Savola K, Kulmala P, et al. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group. Clin Exp Immunol 1999;116:78-83
   PubMedGoogle Scholar
• Graham J, Hagopian WA, Kockum I, et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-55
   PubMed Web of Science ®Google Scholar
• Sanjeevi CB, Hagopian WA, Landin-Olsson M, et al. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 1998;51:281-6
   PubMedGoogle Scholar
• Howson JM, Stevens H, Smyth DJ, et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011;60:2635-44
   PubMed Web of Science ®Google Scholar
• Mäkinen A, Härkonen T, Ilonen J, Knip M. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur J Endocrinol 2008;159:19-26
   PubMedGoogle Scholar
• Salonen KM, Ryhänen S, Härkönen T, et al. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes. Diabetes Metab Res Rev 2013;29:646-54
   PubMedGoogle Scholar
• Lempainen J, Härkönen T, Laine A, et al. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies. Pediatr Diabetes 2013;14:490-6
   PubMed Web of Science ®Google Scholar
• Ilonen J, Hammais A, Laine AP, et al. Patterns of beta-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life. Diabetes 2013;62:3636-40
   PubMed Web of Science ®Google Scholar
• Achenbach P, Lampasona V, Landherr U, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia 2009;52:1881-8
   PubMed Web of Science ®Google Scholar
• The TRIGR Study Group. Study design of the Trial to Reduce IDDM in the Genetically at Risk (TRIGR). Pediatr Diabetes 2007;8:117-37
   PubMedGoogle Scholar
• Hagopian WA, Erlich H, Lernmark A, et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011;12:733-43
   PubMedGoogle Scholar
• TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci 2008;1150:1-13
   Web of Science ®Google Scholar
• Peakman M. Immunological pathways to beta-cell damage in Type 1 diabetes. Diabet Med 2013;30:147-54
   PubMed Web of Science ®Google Scholar
• Herold KC, Brooks-Worrell B, Palmer J, et al. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 2009;58:2588-95
   PubMedGoogle Scholar
• Oresic M. Metabolomics in the studies of islet autoimmunity and type 1 diabetes. Rev Diabet Stud 2012;9:236-47
   PubMedGoogle Scholar
• Vaarala O. Human intestinal microbiota and type 1 diabetes. Curr Diab Rep 2013;13:601-7
   PubMedGoogle Scholar
• Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of Type I diabetes–the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-403
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Rewers M, Reunanen A, et al. Increasing trend in type 1 (insulin-dependent) diabetes mellitus in childhood in Finland. Analysis of age, calendar time and birth cohort effects during 1965 to 1984. Diabetologia 1991;34:282-7
   PubMed Web of Science ®Google Scholar
• Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013;310:427-8
   PubMed Web of Science ®Google Scholar
• Berhan Y, Waernbaum I, Lind T, et al. Thirty years of prospective nationwide incidence of childhood type 1 diabetes: the accelerating increase by time tends to level off in Sweden. Diabetes 2011;60:577-81
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001;358:221-9
   PubMed Web of Science ®Google Scholar
• Marciulionyte D, Williams AJ, Bingley PJ, et al. A comparison of the prevalence of islet autoantibodies in children from two countries with differing incidence of diabetes. Diabetologia 2001;44:16-21
   PubMedGoogle Scholar
• Kondrashova A, Viskari H, Kulmala P, et al. Signs of beta-cell autoimmunity in nondiabetic schoolchildren: a comparison between Russian Karelia with a low incidence of type 1 diabetes and Finland with a high incidence rate. Diabetes Care 2007;30:95-100
   PubMed Web of Science ®Google Scholar
• Vaarala O, Atkinson MA, Neu J. The “perfect storm” for type 1 diabetes. The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008;57:2555-62
   PubMed Web of Science ®Google Scholar
• Wegmann DR, Eisenbarth GS. It’s insulin. J Autoimmun 2000;15:286-91
   PubMedGoogle Scholar
• Kurtz AB, Matthews JA, Mustaffa BE, et al. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia 1980;18:147-50
   PubMedGoogle Scholar
• van Haeften TW, Voetberg GA, Gerich JE, van der Veen EA. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia. J Clin Endocrinol Metab 1989;69:1059-64
   PubMed Web of Science ®Google Scholar
• Schlosser M, Mueller PW, Torn C, et al. Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodies. Diabetologia 2010;53:2611-20
   PubMed Web of Science ®Google Scholar
• Ottesen JL, Nilsson P, Jami J, et al. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia 1994;37:1178-85
   PubMed Web of Science ®Google Scholar
• Vaarala O, Saukkonen T, Savilahti E, et al. Development of immune response to cow’s milk proteins in infants receiving cow’s milk or hydrolyzed formula. J Allergy Clin Immunol 1995;96:917-23
   PubMedGoogle Scholar
• Vaarala O. Is it dietary insulin? Ann N Y Acad Sci 2006;1079:350-9
   PubMed Web of Science ®Google Scholar
• Vaarala O, Knip M, Paronen J, et al. Cow’s milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes 1999;48:1389-94
   PubMed Web of Science ®Google Scholar
• Achenbach P, Koczwara K, Knopff A, et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004;114:589-97
   PubMedGoogle Scholar
• Pugliese A. Central and peripheral autoantigen presentation in immune tolerance. Immunology 2004;111:138-46
   PubMedGoogle Scholar
• Craig ME, Nair S, Stein H, Rawlinson WD. Viruses and type 1 diabetes: a new look at an old story. Pediatr Diabetes 2013;14:149-58
   PubMedGoogle Scholar
• Serreze DV, Ottendorfer EW, Ellis TM, et al. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000;49:708-11
   PubMedGoogle Scholar
• Wucherpfennig KW. T cell receptor crossreactivity as a general property of T cell recognition. Mol Immunol 2004;40:1009-17
   PubMedGoogle Scholar
• Roep BO, Hiemstra HS, Schloot NC, et al. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci 2002;958:163-5
   PubMedGoogle Scholar
• Honeyman MC, Stone NL, Falk BA, et al. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 2010;184:2204-10
   PubMed Web of Science ®Google Scholar
• Jalonen T, Isolauri E, Heyman M, et al. Increased beta-lactoglobulin absorption during rotavirus enteritis in infants: relationship to sugar permeability. Pediatr Res 1991;30:290-3
   PubMedGoogle Scholar
• Ahmed T, Sumazaki R, Shin K, et al. Humoral immune and clinical responses to food antigens following acute diarrhoea in children. J Paediatr Child Health 1998;34:229-32
   PubMedGoogle Scholar
• Mäkelä M, Vaarala O, Hermann R, et al. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 2006;27:54-61
   PubMed Web of Science ®Google Scholar
• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002;347:911-20
   PubMed Web of Science ®Google Scholar
• Viskari H, Ludvigsson J, Uibo R, et al. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005;48:1280-7
   PubMed Web of Science ®Google Scholar
• Skyler JS. Primary and secondary prevention of Type 1 diabetes. Diabet Med 2013;30:161-9
   PubMedGoogle Scholar
• Peakman M, von Herrath M. Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential. Diabetes 2010;59:2087-93
   PubMed Web of Science ®Google Scholar
• Norris JM, Barriga K, Hoffenberg EJ, et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005;293:2343-51
   PubMed Web of Science ®Google Scholar
• Ivarsson A, Hernell O, Stenlund H, Persson LA. Breast-feeding protects against celiac disease. Am J Clin Nutr 2002;75:914-21
   PubMed Web of Science ®Google Scholar
• Knip M, Virtanen SM, Akerblom HK. Infant feeding and the risk of type 1 diabetes. Am J Clin Nutr 2010;91:1506S-13S
   PubMed Web of Science ®Google Scholar
• Vaarala O, Ilonen J, Ruohtula T, et al. Removal of Bovine Insulin From Cow’s Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study. Arch Pediatr Adolesc Med 2012;166:608-14
   PubMedGoogle Scholar
• Visser JT, Bos NA, Harthoorn LF, et al. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab Res Rev 2012;28:505-13
   PubMed Web of Science ®Google Scholar
• Knip M, Virtanen SM, Seppä K, et al. Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med 2010;363:1900-8
   PubMed Web of Science ®Google Scholar
• Knip M, Åkerblom HK, Becker D, et al. Hydrolyzed infant formula and early beta-cell autoimmunity: a randomized clinical trial. JAMA 2014;311:2279-87
   PubMed Web of Science ®Google Scholar
• Virtanen SM, Nevalainen J, Kronberg-Kippila C, et al. Food consumption and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. Am J Clin Nutr 2012;95:471-8
   PubMed Web of Science ®Google Scholar
• Lamb MM, Miller M, Seifert JA, et al. The effect of childhood cow’s milk intake and HLA-DR genotype on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young. Pediatr Diabetes 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial–Type 1. Diabetes Care 2005;28:1068-76
   PubMed Web of Science ®Google Scholar